Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation
George T. De Sanctis, … , Francis H.Y. Green, Jeffrey M. Drazen
George T. De Sanctis, … , Francis H.Y. Green, Jeffrey M. Drazen
Published February 15, 1999
Citation Information: J Clin Invest. 1999;103(4):507-515. https://doi.org/10.1172/JCI4017.
View: Text | PDF
Article

Interleukin-8 receptor modulates IgE production and B-cell expansion and trafficking in allergen-induced pulmonary inflammation

  • Text
  • PDF
Abstract

We examined the role of the interleukin-8 (IL-8) receptor in a murine model of allergen-induced pulmonary inflammation using mice with a targeted deletion of the murine IL-8 receptor homologue (IL-8r–/–). Wild-type (Wt) and IL-8r–/– mice were systemically immunized to ovalbumin (OVA) and were exposed with either single or multiple challenge of aerosolized phosphate-buffered saline (OVA/PBS) or OVA (OVA/OVA). Analysis of cells recovered from bronchoalveolar lavage (BAL) revealed a diminished recruitment of neutrophils to the airway lumen after single challenge in IL-8r–/– mice compared with Wt mice, whereas multiply challenged IL-8r–/– mice had increased B cells and fewer neutrophils compared with Wt mice. Both Wt and IL-8r–/– OVA/OVA mice recruited similar numbers of eosinophils to the BAL fluid and exhibited comparable degrees of pulmonary inflammation histologically. Both total and OVA-specific IgE levels were greater in multiply challenged IL-8r–/– OVA/OVA mice than in Wt mice. Both the IL-8r–/– OVA/OVA and OVA/PBS mice were significantly less responsive to methacholine than their respective Wt groups, but both Wt and IL-8r mice showed similar degrees of enhancement after multiple allergen challenge. The data demonstrate that the IL-8r modulates IgE production, airway responsiveness, and the composition of the cells (B cells and neutrophils) recruited to the airway lumen in response to antigen.

Authors

George T. De Sanctis, James A. MacLean, Shixin Qin, Walter W. Wolyniec, Hartmut Grasemann, Chandri N. Yandava, Aiping Jiao, Thomas Noonan, Joan Stein-Streilein, Francis H.Y. Green, Jeffrey M. Drazen

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Schematic representation of the sensitization and challenge protocols. F...
Schematic representation of the sensitization and challenge protocols. For the acute challenge protocol (a), mice were sensitized and boosted on days 1 and 7 with OVA, received a single aerosol challenge of either OVA or PBS on day 14, and were studied on day 15. For the chronic challenge protocol (b), mice were sensitized and boosted on days 1 and 7, received repeated aerosol challenge of either OVA or PBS on days 14–20, and were studied on day 21. IP, intraperitoneally; OVA, ovalbumin.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts